These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 26925703

  • 1. Mosquito saliva induced cutaneous events augment Chikungunya virus replication and disease progression.
    Agarwal A, Joshi G, Nagar DP, Sharma AK, Sukumaran D, Pant SC, Parida MM, Dash PK.
    Infect Genet Evol; 2016 Jun; 40():126-135. PubMed ID: 26925703
    [Abstract] [Full Text] [Related]

  • 2. Aedes Aegypti saliva enhances chikungunya virus replication in human skin fibroblasts via inhibition of the type I interferon signaling pathway.
    Wichit S, Diop F, Hamel R, Talignani L, Ferraris P, Cornelie S, Liegeois F, Thomas F, Yssel H, Missé D.
    Infect Genet Evol; 2017 Nov; 55():68-70. PubMed ID: 28866137
    [Abstract] [Full Text] [Related]

  • 3. Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus.
    Thangamani S, Higgs S, Ziegler S, Vanlandingham D, Tesh R, Wikel S.
    PLoS One; 2010 Aug 12; 5(8):e12137. PubMed ID: 20711354
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology.
    Teo TH, Her Z, Tan JJ, Lum FM, Lee WW, Chan YH, Ong RY, Kam YW, Leparc-Goffart I, Gallian P, Rénia L, de Lamballerie X, Ng LF.
    J Virol; 2015 Aug 12; 89(15):7955-69. PubMed ID: 25995257
    [Abstract] [Full Text] [Related]

  • 6. Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.
    Acharya D, Paul AM, Anderson JF, Huang F, Bai F.
    PLoS Negl Trop Dis; 2015 Aug 12; 9(10):e0004139. PubMed ID: 26484530
    [Abstract] [Full Text] [Related]

  • 7. Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects.
    Hibl BM, Dailey Garnes NJM, Kneubehl AR, Vogt MB, Spencer Clinton JL, Rico-Hesse RR.
    PLoS Negl Trop Dis; 2021 Jun 12; 15(6):e0009427. PubMed ID: 34106915
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis.
    Locke MC, Fox LE, Dunlap BF, Young AR, Monte K, Lenschow DJ.
    J Virol; 2022 Jan 12; 96(1):e0114321. PubMed ID: 34668781
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proteomics profiling of chikungunya-infected Aedes albopictus C6/36 cells reveal important mosquito cell factors in virus replication.
    Lee RC, Chu JJ.
    PLoS Negl Trop Dis; 2015 Mar 12; 9(3):e0003544. PubMed ID: 25738640
    [Abstract] [Full Text] [Related]

  • 13. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
    Jones JE, Long KM, Whitmore AC, Sanders W, Thurlow LR, Brown JA, Morrison CR, Vincent H, Peck KM, Browning C, Moorman N, Lim JK, Heise MT.
    mBio; 2017 Nov 14; 8(6):. PubMed ID: 29138302
    [Abstract] [Full Text] [Related]

  • 14. A comparison of Chikungunya virus infection, progression, and cytokine profiles in human PMA-differentiated U937 and murine RAW264.7 monocyte derived macrophages.
    Guerrero-Arguero I, Høj TR, Tass ES, Berges BK, Robison RA.
    PLoS One; 2020 Nov 14; 15(3):e0230328. PubMed ID: 32163514
    [Abstract] [Full Text] [Related]

  • 15. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.
    Cook LE, Locke MC, Young AR, Monte K, Hedberg ML, Shimak RM, Sheehan KCF, Veis DJ, Diamond MS, Lenschow DJ.
    J Virol; 2019 Dec 12; 94(1):. PubMed ID: 31619554
    [Abstract] [Full Text] [Related]

  • 16. Chikungunya virus pathogenesis: From bedside to bench.
    Couderc T, Lecuit M.
    Antiviral Res; 2015 Sep 12; 121():120-31. PubMed ID: 26159730
    [Abstract] [Full Text] [Related]

  • 17. Chikungunya virus pathogenesis and immunity.
    Gasque P, Couderc T, Lecuit M, Roques P, Ng LF.
    Vector Borne Zoonotic Dis; 2015 Apr 12; 15(4):241-9. PubMed ID: 25897810
    [Abstract] [Full Text] [Related]

  • 18. Human keratinocytes restrict chikungunya virus replication at a post-fusion step.
    Bernard E, Hamel R, Neyret A, Ekchariyawat P, Molès JP, Simmons G, Chazal N, Desprès P, Missé D, Briant L.
    Virology; 2015 Feb 12; 476():1-10. PubMed ID: 25496825
    [Abstract] [Full Text] [Related]

  • 19. Vector competence of populations of Aedes aegypti from three distinct cities in Kenya for chikungunya virus.
    Agha SB, Chepkorir E, Mulwa F, Tigoi C, Arum S, Guarido MM, Ambala P, Chelangat B, Lutomiah J, Tchouassi DP, Turell MJ, Sang R.
    PLoS Negl Trop Dis; 2017 Aug 12; 11(8):e0005860. PubMed ID: 28820881
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression.
    Neupane B, Acharya D, Nazneen F, Gonzalez-Fernandez G, Flynt AS, Bai F.
    Front Immunol; 2020 Aug 12; 11():588382. PubMed ID: 33304351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.